FDA Inspection 1164947 — Herve Bachelez, MD

Herve Bachelez, MD — FEI 3021343105

The FDA completed an inspection of Herve Bachelez, MD on Mar 4, 2022 in Paris. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 4, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Paris (France)

Additional Details

Clinical Investigator (CI)